UK Pension Superfunds Set to Double Deal Volume in 2026

UK pension superfund transaction counts are on track to double in 2026, rising from four completed deals to roughly eight to ten as two new providers join Clara Pensions and TPT Retirement Solutions. Superfund pricing typically runs 10 to 15 percent below insurer buyout cost.

That wedge is not a discount on the same product. It is the market's price for a different tier of member security, and a scheme actuary has to size it before a trustee board can weigh it.

Key Takeaways

• £70 billion of total UK pension risk transfer volume forecast for 2026, roughly 15 percent above 2025, with more than £50 billion in bulk annuities absorbing insurer capacity.
• Three to five years is the buyout queue larger schemes face once they approach the market, driven by data cleansing backlogs and administrator capacity rather than funding weakness.
• 99 percent over a rolling five-year window is the superfund capital standard, a repeating one-in-a-hundred tail reassessed across a multi-decade run-off, against Solvency II's 99.5 percent one-year test plus an FSCS guarantee.
• Gilts plus 0.75 percent is the fixed regulatory discount rate for superfund technical provisions, while insurer pricing runs off each carrier's own illiquid asset portfolio and can undercut it.
• One active provider to four inside a single year, split between bridge-to-buyout and run-on structures that carry different governance dynamics.

Why Volume Is Doubling

Two forces are converging, and neither is new alone. UK defined benefit funding has strengthened since the 2022 gilt crisis, and insurer bulk annuity capacity has not kept pace with the volume of schemes now ready to transact.

WTW's outlook puts total UK pension risk transfer volume at £70 billion for the year, roughly 15 percent above 2025, split between more than £50 billion in bulk annuities and up to £20 billion in longevity swaps. LCP forecasts £40 billion to £55 billion in buy-in and buyout volume and more than 150,000 members moving through to full buyout in 2026, roughly three times 2024's throughput. That is a great deal of insurer capacity absorbed by a small number of large, well-funded schemes able to pay for priority.

The schemes left in the queue are not badly funded. They are more often mid-sized or smaller schemes for whom the fixed costs of a bespoke insurer process, and the wait for an underwriting slot, make buyout a real but distant destination. Industry estimates put buyout queues at three to five years once a larger scheme first approaches the market.

Regulatory friction has eased alongside. The Pension Schemes Act 2026 establishes a statutory authorization and supervision framework for superfunds, replacing the interim regime The Pensions Regulator has run since 2020. A consultation on detailed regulations is expected in mid-2026, with the full regime not applying until early 2028. The doubling of deal volume therefore happens under the interim TPR assessment process, so trustees transacting in the next 18 months rely on discretionary sign-off rather than a codified authorization standard.

What the 10 to 15 Percent Actually Buys

The structural difference is not cosmetic. An insurer buyout is a contract of insurance: liabilities become the insurer's, supervised by the Prudential Regulation Authority under Solvency II, and if the insurer fails the Financial Services Compensation Scheme provides a 100 percent guarantee for existing pension policyholders. A superfund is a consolidation vehicle regulated by TPR, backed by a ring-fenced capital buffer rather than a Solvency II balance sheet, with no FSCS-equivalent behind it.

The buffer is sized so that, with scheme assets, there is a 99 percent probability of remaining funded at or above technical provisions over a rolling five-year horizon. Read carefully, that is a repeating one-in-a-hundred tail risk rather than a one-time test at entry. Across a multi-decade run-off, a capital adequacy test re-applied every five years compounds differently than a point-in-time solvency check, and that is the detail most often skipped when a superfund quote is set beside a Solvency II-backed one.

The pricing bases differ for the same structural reason. Superfund technical provisions use a discount rate of gilts plus 0.75 percent per annum, a fixed regulatory margin. Insurer buyout pricing is built from each carrier's own portfolio, referencing swap rates and credit spreads on the illiquid assets backing the annuity book. When insurers are earning attractive spread income, their pricing can undercut a superfund's fixed basis entirely, which is why TPR's own engagement response notes that "some insurers can offer cheaper pricing than superfunds". The 10 to 15 percent discount is therefore not universal; it holds in the segment where insurer appetite is thinner.

That makes the residual risk statable as a number rather than a narrative. Solvency II capital held to a 99.5 percent one-year value-at-risk standard, with the FSCS behind it, leaves a shortfall probability that is vanishingly small and backstopped if it occurs. A superfund accepts a residual shortfall probability on the order of one percent per five-year window, with no backstop, in exchange for a price 10 to 15 percent lower and a faster exit than a three-to-five-year queue. For a sponsor facing covenant deterioration, or a scheme too small to price competitively with insurers, that trade can be the correct answer.

The counterfactual matters as much as the comparison. Clara's Debenhams transaction, its first involving a scheme already in Pension Protection Fund assessment, restored 10,400 members from PPF compensation levels, typically 90 percent of full benefit for non-pensioners, to 100 percent of promised pension, with £4 million of back-payments and an additional £34 million of dedicated Clara capital on top of the £600 million transferred. Against continued PPF assessment, that improves member outcomes outright. Against a live insurer quote for a solvent scheme with an ongoing sponsor, which is the more common comparison, the answer runs the other way.

Four Providers Change the Due Diligence

Since Clara's first transaction in November 2023 it has effectively been the only active commercial superfund in the UK. That changes this year.

TPT Retirement Solutions entered TPR's assessment process in October 2025 with a £1 billion run-on model that shares surplus with members, a structural departure from Clara's bridge-to-buyout approach, where the superfund holds liabilities only until conditions allow an eventual insurer buyout. LCP expects two further entrants to complete assessment during 2026, taking the market from one active provider to four.

With only Clara active, the practical question was binary: is a superfund transfer appropriate for this scheme. With four providers offering genuinely different structures, trustees and their advisors have to underwrite provider solvency, investment strategy and governance across multiple counterparties rather than evaluate the superfund concept in the abstract.

The two models do not stress-test the same way. A run-on structure sharing surplus with members carries different long-run incentive and governance dynamics than a bridge built to exit into an insurer buyout within five to ten years, and the assumptions that matter most, particularly the sustainability of the sponsor's ongoing capital commitment, differ between them. Clara's completed book, Wates at £210 million, Church Mission Society at £55 million, Videndum at £43 million under a new small-scheme structure, is five transactions of varying size against which a new entrant has no track record at all.

More providers should compress pricing and reduce the concentration risk visible on the insurer side, where three of eleven active bulk annuity insurers changed ownership to international investors during 2025 and 2026. What it removes is the shortcut. Each entrant needs its own capital adequacy assessment, and the comparative frameworks to run one across structurally different models did not exist a year ago, because there was only one structure to compare against.